Benzinga | Nov 5, 2020 05:46PM EST

Aprea Therapeutics Q3 EPS $(0.58) Up From $(5.29) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.58) per share. This is a 89.04 percent increase over losses of $(5.29) per share from the same period last year.